Brief: Carl Zeiss Meditec Expects Revenue To Return To Moderate Growth in 2024/25

Carl Zeiss Meditec AG

12/02/2025 06:08

Feb 12 (Reuters) - CARL ZEISS MEDITEC AG  AFXG.DE :
    * CARL ZEISS MEDITEC ACHIEVES SLIGHT REVENUE GROWTH IN FIRST
THREE
MONTHS OF 2024/25
    * Q1 ORDER ENTRY AND ORDER BACKLOG INCREASED SIGNIFICANTLY.
EBITA 1  DECLINED TO AROUND EUR 35.2M (PRIOR YEAR: EUR 46.0M)
    * Q1 EBITA MARGIN WAS 7.2% (PRIOR YEAR: 9.7%)
    * Q1 REVENUE AT €490.5M, UP 3.2%
    * Q1 EPS AT €0.18, DOWN FROM €0.42
    * CARL ZEISS MEDITEC IS EXPECTING GLOBAL MACROECONOMIC
SITUATION
TO REMAIN CHALLENGING IN 2024/25
    * OUTLOOK 24/25: ANTICIPATES NEITHER A RAPID RECOVERY IN
INVESTMENT CLIMATE FOR EQUIPMENT NOR ANY REDUCTION IN PRESSURE
ON CONSUMER SPENDING ON ELECTIVE PROCEDURES
    * OUTLOOK 24/25: REVENUE IS EXPECTED TO RETURN TO MODERATE
GROWTH
    * OUTLOOK 24/25: EBITA AND EBITA MARGIN ARE EXPECTED TO BE
STABLE
OR SLIGHTLY HIGHER IN 2024/25 FISCAL YEAR

Further company coverage:  AFXG.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))